From the División de Anestesiología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile (GCE, SP, MFE, HA, AMV, FRA, VP) and Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University School of Medicine, New York, New York, USA (GCE).
Eur J Anaesthesiol. 2018 May;35(5):343-348. doi: 10.1097/EJA.0000000000000807.
Postoperative vomiting (POV) is a frequent complication of tonsillectomy in children. In adult patients undergoing abdominal surgeries, the use of intravenous lidocaine infusion can prevent POV.
To evaluate the anti-emetic effect of an intravenous lidocaine infusion used as an adjuvant to general anaesthesia, in children undergoing elective ear, nose and throat surgery.
Double-blind, randomised, controlled study.
Hospital-based, single-centre study in Chile.
ASA I-II children, aged 2 to 12 years, scheduled for elective tonsillectomy.
We standardised the induction and maintenance of anaesthesia. Patients were randomly allocated to lidocaine (1.5 mg kg intravenous lidocaine over 5 min followed by 2 mg kg h) or 0.9% saline (at the same rate and volume). Infusions were continued until the end of the surgery.
Presence of at least one episode of vomiting, retching or both in the first 24 h postoperatively (POV).
Plasma concentrations of lidocaine and postoperative pain.
Ninety-two children were enrolled. Primary outcome data were available for 91. In the Lidocaine group, 28 of 46 patients (60.8%) experienced POV, compared with 37 of 45 patients (82.2%) in the Saline group [difference in proportions 21.3% (95% confidence interval (CI) 2.8 to 38.8), P = 0.024]. The intention-to-treat analysis showed that when we assumed that the patient in the Saline group lost to follow-up did not have POV, the difference in proportions decreased to 19.6% (95% CI, 0.9 to 37.2), with an unadjusted odds ratio of 0.38 (95% CI, 0.15 to 0.97, P = 0.044). The odds of having POV were 62% less likely in those patients receiving lidocaine compared with patients in the Saline group. The mean lidocaine plasma concentration was 3.91 μg ml (range: 0.87 to 4.88).
Using an intravenous lidocaine infusion as an adjuvant to general anaesthesia decreased POV in children undergoing elective tonsillectomy.
ClinicalTrials.gov Identifier: NCT01986309.
术后呕吐(POV)是儿童扁桃体切除术后的常见并发症。在接受腹部手术的成年患者中,静脉注射利多卡因输注可预防 POV。
评估静脉注射利多卡因输注作为辅助全身麻醉,在择期耳鼻喉手术的儿童中的止吐效果。
双盲、随机、对照研究。
智利的一家医院内、单中心研究。
ASA I-II 级儿童,年龄 2 至 12 岁,择期行扁桃体切除术。
我们标准化了麻醉的诱导和维持。患者随机分配至利多卡因(1.5mg/kg 静脉利多卡因输注 5 分钟,然后 2mg/kg/h)或 0.9%生理盐水(以相同的速度和体积)。输注持续到手术结束。
术后 24 小时内至少发生一次呕吐、干呕或两者兼有(POV)。
利多卡因的血浆浓度和术后疼痛。
共纳入 92 名儿童。91 名儿童可提供主要结局数据。利多卡因组 46 名患者中有 28 名(60.8%)发生 POV,而生理盐水组 45 名患者中有 37 名(82.2%)[比例差异 21.3%(95%置信区间(CI)2.8 至 38.8),P=0.024]。意向治疗分析表明,当我们假设生理盐水组中失访的患者未发生 POV 时,比例差异降至 19.6%(95%CI,0.9 至 37.2),未调整的优势比为 0.38(95%CI,0.15 至 0.97,P=0.044)。与生理盐水组相比,接受利多卡因的患者发生 POV 的可能性低 62%。利多卡因的平均血浆浓度为 3.91μg/ml(范围:0.87 至 4.88)。
在择期行扁桃体切除术的儿童中,静脉注射利多卡因输注作为全身麻醉的辅助剂可减少 POV。
ClinicalTrials.gov 标识符:NCT01986309。